The Value of Academic-Industry Partnerships

More than a decade ago, the NIH Roadmap and the FDA Critical Path Report brought significant public attention and new programmatic efforts to advance sponsored and translational research. These programs act as bridges between the promise of bioscience discoveries and the advancement of new biomedical innovations to improve the lives of patients.Of particular importance for accelerating translational research and overcoming the challenging environment for bioscience innovation is advan